You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 10,307,376


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,307,376 protect, and when does it expire?

Patent 10,307,376 protects CONTRAVE and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 10,307,376
Title:Methods for administering weight loss medications
Abstract: Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications.
Inventor(s): McKinney; Anthony A. (San Diego, CA), Tollefson; Gary (Indianapolis, IN), Weber; Eckard (San Diego, CA), Soltero; Rick (Holly Springs, NC)
Assignee: Nalpropion Pharmaceuticals, Inc. (Morristown, NJ)
Application Number:16/101,853
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 10,307,376

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 10,307,376, using it as a case study to explain the key concepts and processes involved in patent claims and scope.

What is a Patent?

A patent is a form of intellectual property that grants the inventor exclusive rights to make, use, and sell their invention for a specified period, typically 20 years from the filing date of the patent application[5].

The Role of the USPTO

The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO evaluates patent applications to ensure they meet the criteria for patentability, including novelty, non-obviousness, and enablement[2].

Patent Application Process

The process of obtaining a patent involves several steps:

  • Provisional Patent Application: This is often the first step, providing a temporary protection for 12 months while the inventor prepares for a non-provisional application[5].
  • Non-Provisional Patent Application: This is the formal application that includes detailed descriptions, drawings, and claims. It is reviewed by the USPTO to determine patentability[5].
  • Patent Prosecution: This is the examination process where the patent examiner reviews the application, and the applicant may need to respond to office actions, amend claims, or appeal decisions[5].

Understanding Patent Claims

Patent claims define the scope of the invention and are the legal boundaries of what is protected by the patent. There are two main types of claims:

  • Independent Claims: These stand alone and define the invention without reference to other claims.
  • Dependent Claims: These refer back to an independent claim and further limit the scope of the invention[3].

Metrics for Measuring Patent Scope

To assess the scope of a patent, metrics such as independent claim length and independent claim count can be used. These metrics help in evaluating the breadth and clarity of the patent claims[3].

Case Study: US Patent 10,307,376

While the specific details of US Patent 10,307,376 are not provided here, we can apply general principles to understand its scope and claims.

Claim Structure

  • Independent Claims: These would outline the core aspects of the invention, defining what is novel and non-obvious.
  • Dependent Claims: These would further specify the invention, often adding additional limitations to the independent claims.

Claim Language

The language used in the claims is critical. Claims must be clear and specific to avoid ambiguity. For example, in AI-related patents, the claims must integrate abstract ideas into practical applications to be considered patent-eligible[4].

Practical Application

To be patent-eligible, the claims must demonstrate a practical application of the invention. For instance, if the patent involves AI, the claims should show how the AI is used to solve a specific problem or improve technology[4].

Patent Allowance Rates

Understanding the probability of receiving a patent can provide context for the patent landscape. The USPTO tracks several allowance rates, including the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates help in assessing the likelihood of a patent being granted based on different criteria[1].

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs), are common in patent prosecution. These procedures allow applicants to continue the examination process, potentially leading to the issuance of a patent[1].

Patent Scope and Quality

The scope of a patent is a critical aspect of patent quality debates. Patents with overly broad or unclear claims can diminish innovation incentives due to increased licensing and litigation costs. Metrics like claim length and count help in evaluating the scope and clarity of patent claims[3].

AI and Patent Eligibility

Recent updates from the USPTO have refined the process for determining the patent eligibility of AI-related inventions. The focus is on whether the claim integrates a judicial exception into a practical application, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[4].

International Patent Considerations

For inventions with global potential, international patent applications, such as those under the Patent Cooperation Treaty (PCT), can be filed. This preserves the right to file patents in multiple countries within a specified timeframe[5].

Costs and Commercial Considerations

The cost of obtaining and maintaining a patent can be significant, ranging from $8,000 to $20,000 for a U.S. non-provisional patent application, and much higher for international patents. Commercial partners often cover these costs, especially if there is a reasonable likelihood of recovering them through licensing or sales[5].

Key Takeaways

  • Patent Claims: Define the legal boundaries of the invention and must be clear and specific.
  • Patent Scope: Metrics like claim length and count help evaluate the breadth and clarity of patent claims.
  • Practical Application: Claims must demonstrate a practical application of the invention to be patent-eligible.
  • Continuation Procedures: Tools like RCEs can extend the examination process, increasing the chances of patent issuance.
  • AI and Patents: Recent USPTO updates clarify the eligibility of AI-related inventions, focusing on practical applications.
  • International Considerations: PCT applications can protect inventions globally, but come with significant costs.

FAQs

What is the purpose of a provisional patent application?

A provisional patent application provides temporary protection for 12 months, allowing the inventor time to prepare for a non-provisional application and to test the market without losing the right to file for a full patent[5].

How are patent claims structured?

Patent claims include independent claims that stand alone and define the invention, and dependent claims that refer back to independent claims and further limit the scope of the invention[3].

What is the significance of practical application in patent claims?

Practical application is crucial as it ensures that the claimed invention offers a concrete technological improvement and is not just an abstract idea. This is particularly important in AI-related patents[4].

What are continuation procedures in patent prosecution?

Continuation procedures, such as Requests for Continued Examination (RCEs), allow applicants to continue the examination process after an initial rejection, potentially leading to the issuance of a patent[1].

How much does it cost to obtain and maintain a patent?

The cost can range from $8,000 to $20,000 for a U.S. non-provisional patent application, and significantly more for international patents. These costs include filing fees, prosecution costs, and maintenance fees over the patent's lifetime[5].

What is the role of the USPTO in the patent process?

The USPTO is responsible for evaluating patent applications to ensure they meet the criteria for patentability, including novelty, non-obviousness, and enablement. It also grants patents and registers trademarks[2].

Sources

  1. Hegde, D., & Marco, A. (n.d.). What Is the Probability of Receiving a US Patent?. The Yale Journal of Law & Technology.
  2. U.S. Patent and Trademark Office (USPTO). (n.d.). U.S. Patent and Trademark Office (USPTO). USA.gov.
  3. Hoover Institution. (2016). Patent Claims and Patent Scope. Hoover Institution.
  4. Mintz. (2024). Understanding the 2024 USPTO Guidance Update on AI Patent. Mintz.
  5. KU Office of Research. (n.d.). Intellectual Property Protection. University of Kansas.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,307,376

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Nalpropion CONTRAVE bupropion hydrochloride; naltrexone hydrochloride TABLET, EXTENDED RELEASE;ORAL 200063-001 Sep 10, 2014 RX Yes Yes ⤷  Subscribe ⤷  Subscribe USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.